Augmentin ES-600 Oral Suspension 42.9mg/600mg per 5mL
Pediatric oral suspension combining amoxicillin trihydrate and clavulanate potassium for treating acute otitis media in children. Falls under HTS 3004.10.50.49 as a mixed combination antibiotic with penicillin derivative, put up in measured doses (100mL bottles) for retail sale. Therapeutic use aligns with chapter notes for mixed products.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If single streptomycin derivative without penicillin
Unmixed streptomycin products classify under 3003, separate from mixed combinations.
If specifically ampicillin or amoxicillin alone
Specific penicillin types have dedicated subheadings before 'other' combinations.
If reconstituted as a non-medicated solution without therapeutic claim
Chapter exclusions apply if not put up for prophylactic/therapeutic uses.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Verify cold chain documentation to maintain suspension stability during import
• Label with full ingredient disclosure and dosage instructions per FDA retail standards
• Test for microbial contamination common in liquid antibiotics to prevent CBP holds
Related Products under HTS 3004.10.50.49
Amoxicillin-Clavulanate Potassium Tablets 875mg/125mg
These combination antibiotic tablets contain amoxicillin (a penicillin derivative with penicillanic acid structure) and clavulanate potassium, used for treating bacterial infections like sinusitis and pneumonia. Classified under HTS 3004.10.50.49 as a mixed product in measured doses for therapeutic use, not covered by other chapter exclusions. Put up in retail packaging such as blister packs of 20 tablets.
Piperacillin-Tazobactam Injection 4.5g Vial
Sterile injectable powder combining piperacillin sodium (penicillin derivative) and tazobactam for IV treatment of serious infections. HTS 3004.10.50.49 covers this as a combination antibiotic in measured doses (single-use vials) for retail/hospital sale, mixed per chapter note (b).
Ampicillin-Sulbactam Injection 3g Vial
Combination IV antibiotic with ampicillin (penicillin with penicillanic structure) and sulbactam for intra-abdominal infections. Classified in HTS 3004.10.50.49 as 'other' combination antibiotics in measured single-dose vials for therapeutic retail distribution.
Cefoperazone-Sulbactam 1.5g Powder for Injection
Beta-lactam combination of cefoperazone (penicillin derivative) and sulbactam, put up in 1.5g measured vials for reconstitution and IV use against resistant bacteria. HTS 3004.10.50.49 applies to this mixed therapeutic antibiotic for retail pharmacy sale.
Amoxicillin-Clavulanate Extended-Release Tablets 1000mg/62.5mg
XR formulation combining amoxicillin and clavulanate for twice-daily dosing in respiratory infections. This mixed penicillin-based antibiotic in measured tablet doses for retail qualifies under HTS 3004.10.50.49 'other combination antibiotics'.
Ticarcillin-Clavulanate IV 3.1g Infusion Bags
Premixed IV solution of ticarcillin (penicillin derivative) and clavulanate for hospital use in septicemia. HTS 3004.10.50.49 as mixed combination in measured retail doses (50mL bags), therapeutic per chapter scope.